Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Immunological and pathological characterization of fatal rebound MS activity following natalizumab withdrawal.
Innate Immunotherapeutics announces clinical trial fully enrolled and receives strong interest from potential Pharma partners
A subtraction pipeline for automatic detection of new appearing multiple sclerosis lesions in longitudinal studies.
Diagnostic modalities in multiple sclerosis: Perspectives in children.
Multiple sclerosis.
Support our campaign for better treatment for people with MS.
Genome and transcriptome of the porcine whipworm Trichuris suis.
Multiple sclerosis: Reactivation of Epstein-Barr or herpes viruses not associated with MS relapse.
Neuromyelitis optica spectrum disorders.
More severe manifestations and poorer short-term prognosis of ganglioside-associated guillain-barré syndrome in northeast china.
Decreased levels of repulsive guidance molecule A in association with beneficial effects of repeated intrathecal triamcinolone acetonide application in progressive multiple sclerosis patients.
Predictors of recurrence following an initial episode of transverse myelitis.
Multiparity in women with multiple sclerosis causes less long-term disability: No.
Neurological and psychiatric disorders as a neuroglial failure.
Commentary on Pique et al.'s paper entitled: Peripheral late reactivation of a previously typical monofocal Balo's concentric sclerosis lesion.
Evaluating sex hormone levels in reproductive age women with multiple sclerosis and their relationship with disease severity.
Brain Tissue Volumes and Perfusion Change with the Number of Optic Neuritis Attacks in Relapsing Neuromyelitis Optica: A Voxel-Based Correlation Study.
Assessing risks of multiple sclerosis therapies.
Sex-specific extent and severity of white matter damage in multiple sclerosis: Implications for cognitive decline.
Comparing long-term results of PASAT and SDMT scores in relation to neuropsychological testing in multiple sclerosis.
Aberrant Type I Interferon Regulation in Autoimmunity: Opposite Directions in MS and SLE, Shaped by Evolution and Body Ecology.
Established and novel disease-modifying treatments in multiple sclerosis.
Current topics in therapeutic plasmapheresis.
(1)H magnetic resonance spectroscopy in multiple sclerosis and related disorders.
Correction: Characterization of Microcirculation in Multiple Sclerosis Lesions by Dynamic Texture Parameter Analysis (DTPA).
Pages
« first
‹ previous
…
547
548
549
550
551
552
553
554
555
…
next ›
last »